Clinical Trials Directory

Trials / Completed

CompletedNCT06092073

Bilateral Recto-Intercostal Fascial Plane Block in Epigastric Hernia Repair

Efficacy and Safety of Bilateral Recto-Intercostal Fascial Plane Block on Perioperative Analgesia in Epigastric Hernia Repair : A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the efficacy and safety bilateral recto-intercostal fascial plane block (RIFPB) in epigastric hernia.

Detailed description

Epigastric hernias are usually occult in obese patients, and their symptoms may mimic peptic ulcer or gallbladder disease . Hernia repair is associated with considerable postoperative pain. The recto-intercostal fascial plane block (RIFPB) is a new novel approach that was developed by Tulgar et al., 2023 who hypothesized that when we inject a local anesthetic into the interfacial plane just inferolateral to the xiphoid, between the rectus abdominis muscle and the 6-7th costal cartilages (hence, between the cartilages and the intercostal muscles between them), blockade of the anterior branches of the nerves passing through this area can be guaranteed.

Conditions

Interventions

TypeNameDescription
PROCEDURErecto-intercostal fascial plane blockPatients will receive bilateral recto-intercostal fascial plane block using 20 mL of bupivacaine 0.25% on each side.
DRUGbupivacainebupivacaine 0.25%

Timeline

Start date
2023-10-21
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2023-10-23
Last updated
2026-01-30

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06092073. Inclusion in this directory is not an endorsement.